NCT06355752

Brief Summary

The use of the dry needling technique has become widespread in recent years for the treatment of musculoskeletal pain. Although dry needling has been shown to be effective in the treatment of shoulder pain, elbow pain, headache, etc., we do not yet have a clear understanding of the mechanisms of action that justify its beneficial effects. In this study, we propose to analyse the biochemical markers of pain generated by the application of a dry needling technique on the lumbar musculature in patients with mechanical lumbar pain of non-specific origin. The aim of this study will be to evaluate the effects of dry needling technique on the plasmatic concentration of biochemical markers.Furthermore, the test subjects will be randomly distributed into two groups. An experimental group where the subjects will receive a real dry needling technique. Another group will be treated with a sham technique.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
36

participants targeted

Target at P25-P50 for not_applicable low-back-pain

Timeline
Completed

Started Apr 2024

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

April 4, 2024

Completed
5 days until next milestone

First Posted

Study publicly available on registry

April 9, 2024

Completed
3 days until next milestone

Study Start

First participant enrolled

April 12, 2024

Completed
8 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 15, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 15, 2024

Completed
Last Updated

December 19, 2024

Status Verified

December 1, 2024

Enrollment Period

8 months

First QC Date

April 4, 2024

Last Update Submit

December 18, 2024

Conditions

Keywords

Low Back PainDry needlingBiochemical Markers

Outcome Measures

Primary Outcomes (1)

  • Extracting Blood Samples and Obtaining Serum/Plasma

    Serum samples will be extracted by venipuncture at the cubital fossa, according to a standardized protocol. Blood will be collected in a tube for serum (Vacutainer SST II Advance, model 367953) and a tube for plasma (Vacutainer PST II Advance, model 367374) separation. Substances related to antinociception will be determined later: Dopamine, adrenaline, norepinephrine, cortisol.

    Change from Baseline concentration at 2 hours

Study Arms (2)

Real dry needling

EXPERIMENTAL

Subjects included in this group will receive a session with dry needling in the quadratus lumborum muscle.

Other: Dry needling of lumbar iliocostalis muscle

Sham dry needling

SHAM COMPARATOR

Subjects included in this group will receive a session with sham dry needling in the quadratus lumborum muscle.

Other: Sham dry needling lumbar iliocostalis muscle

Interventions

Subjects will be treated with dry needling to the quadratus lumborum muscle. To do this, the subject will be lying laterally on the contralateral side and with the hip in an adducted position. Ten incisions will be made in the muscle. The head will rest comfortably on a pillow

Real dry needling

Subjects will be treated with dry needling to the quadratus lumborum muscle. To do this, the subject will be lying laterally on the contralateral side and with the hip in an adducted position. The placebo needle will move 10 times imitating the real procedure. The head will rest comfortably on a pillow

Sham dry needling

Eligibility Criteria

Age18 Years - 70 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Mechanical lumbar pain of more than three months of evolution.

You may not qualify if:

  • Medical diagnosis of lumbar disc herniation or protrusion.
  • Low back and leg pain.
  • Pregnancy.
  • Fibromyalgia.
  • Fear of needles.
  • Medication with anticoagulants

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Centro Investigación Fisioterapia y Dolor

Alcalá de Henares, Madrid, 28805, Spain

Location

MeSH Terms

Conditions

Low Back Pain

Condition Hierarchy (Ancestors)

Back PainPainNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • Tomas Gallego-Izquierdo, PhD

    Centro de Investigación Fisioterapia y Dolor

    STUDY CHAIR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
OTHER
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal investigator

Study Record Dates

First Submitted

April 4, 2024

First Posted

April 9, 2024

Study Start

April 12, 2024

Primary Completion

December 15, 2024

Study Completion

December 15, 2024

Last Updated

December 19, 2024

Record last verified: 2024-12

Locations